Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of GSK2340272A in Infants
NCT01003418Phase 2Terminated
- Sponsor
- GSK
- Start
- Nov 2009
- Primary completion
- Nov 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Q-Pan H1N1 in influenza A H1N1 infection (H1N1), sponsored by GSK. Started Nov 2009; status: terminated.
02
Drugs
Q-Pan H1N1
03
Conditions
influenza A H1N1 infection (H1N1)
Beyond the preview
Go deeper on NCT01003418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01003418.